OGN 8-K 2026-07-17

Organon & Co. (OGN) 8-K dated 2026-07-17 — accession 0001193125-26-307767. This URL is the filing, not the OGN hub.

Organon & Co. (OGN) is a drug manufacturers - general company listed on US.

Organon & Co. filed a 8-K on 2026-07-17. Accession 0001193125-26-307767.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OGN revenue for 2025-12-31 was $6.22B. Net income was $187.0M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. OGN currently screens at market cap $2.52B.

Not investment advice. The OGN SEC hub lists recent forms. The stock page is the research view.